Taf + Emtricitabine + Darunavir + Cobicistat Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Darunavir- 800 mg + Cobicistat-1 50 mg + Emtricitabine- 200 mg + TAF-10 mg
Reference Brands: Symtuza(Eu & US)
Category: Anti Viral
Symtuza is a once-daily, complete HIV-1 treatment with Darunavir, Cobicistat, Emtricitabine, and TAF. FDA and EMA approved, it offers high resistance protection and improved safety in a single-tablet regimen.
Manufacture or export Taf + Emtricitabine + Darunavir + Cobicistat? List it or send an offer →
Product Description:
Symtuza is the first once-daily, single-tablet regimen combining Darunavir 800 mg, Cobicistat 150 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide (TAF) 10 mg for the treatment of HIV-1 infection. Approved by both the FDA and EMA, Symtuza is indicated for adults and adolescents (≥12 years, ≥40 kg) who are treatment-naïve or virologically suppressed. The high resistance barrier of Darunavir, boosted by Cobicistat, makes Symtuza ideal for durable viral suppression. Its TAF backbone ensures better renal and bone safety than older TDF-based regimens. Symtuza offers the simplicity of a PI-based single-tablet regimen, enhancing long-term adherence.
Taf + Emtricitabine + Darunavir + Cobicistat — third party manufacturing & bulk supply
Taf + Emtricitabine + Darunavir + Cobicistat is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Taf + Emtricitabine + Darunavir + Cobicistat is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Taf + Emtricitabine + Darunavir + Cobicistat listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Taf + Emtricitabine + Darunavir + Cobici... →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
This combination is used for the treatment of HIV-1 infection. It works by suppressing viral replication, increasing CD4 cell counts, and helping achieve long-term viral suppression when used as part of antiretroviral therapy.
It is made from the active ingredients tenofovir alafenamide (TAF), emtricitabine, darunavir, and cobicistat. TAF and emtricitabine are nucleoside reverse transcriptase inhibitors, darunavir is a protease inhibitor, and cobicistat is a pharmacokinetic enhancer.
A known trade name for this four-drug fixed combination is Symtuza in the USA, EU, and UK.
Symtuza is manufactured by Janssen (Johnson & Johnson) in collaboration with Gilead Sciences.
The generic name is tenofovir alafenamide + emtricitabine + darunavir + cobicistat.
The main brand name is Symtuza.
It is manufactured by Janssen in the EU/USA, with production also handled through their authorized global manufacturing partners.
Related Products
Tenofovir Af + Emtricitabine + Bictegravir
Strength:
Bictegravir-50 mg + Emtricitabine-200 mg + TAF-25 mg
Form: Tablet
Reference Brands: Biktarvy(EU & US)
View Details
Taf + Emtricitabine + Rilpivirine
Strength:
(TAF) – 25 mg + Emtricitabine – 200 mg + Rilpivirine – 25 mg
Form: Tablet
Reference Brands: Odefsey(US & EU)
View Details
Glecaprevir + Pibrentasvir
Strength:
Glecaprevir- 100 mg + Pibrentasvir - 40 mg
Form: Tablet
Reference Brands: Mavyret (US); Maviret (EU)
View Details
Taf + Emtricitabine + Elvitegravir + Cobicistat
Strength:
Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TAF – 10 mg
Form: Tablet
Reference Brands: Genvoya(US & EU)
View Details
Abacavir + Lamivudine Dispersible Tablets
Strength:
120 mg/60 mg
Form: Scored dispersible tablets
Reference Brands:
View DetailsUsually answered within 48 hours | GMP documents shared before you commit
